TRANS Government Research Act

H.R. 10127, titled the "Terminating Radical Attempts to Negate Sex Through Government Research Act" or "TRANS Government Research Act," would bar the use of any federal funds to directly or indirectly conduct, support, or fund research studying the effects of gender-related medical treatment. The bill defines this "covered research" broadly to include studies of surgical procedures, hormone treatments, and puberty blockers used to address a person's perception that they are not their biological sex, as well as research on other methods of altering appearance to differ from one's sex. The bill also defines terms such as "male," "female," and "sex" based on biological reproductive function.

The bill would primarily affect federal agencies and federally funded researchers, such as those working through the National Institutes of Health or other government-supported programs, who study gender-related medical treatments including hormone therapy, puberty blockers, and related surgeries. Universities, hospitals, and research institutions receiving federal grants for such studies could lose funding eligibility for this specific area of research.

The bill was introduced on August 20, 2026, by Rep. Nancy Mace and referred to the House Committee on Energy and Commerce. It has not yet been voted on by the committee or the full House, and would need to pass both chambers of Congress and be signed by the President before becoming law.

Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.